But the FDA also says officials cannot definitively rule out that "a small risk may exist” and that they’ll continue to look into reports regarding more than a dozen drugs.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
